Pharmacological Properties of Diclofenac Sodium and Its Metabolites

Referenser

• Adams S. S., Bough R. G., Cliffe E. E., Lessel B., Mills R. F. N. Absorption, distribution and toxicity of ibuprofen. Toxicol Appl Pharmacol 1969; 15: 310
   PubMed Web of Science ®Google Scholar
• Attallah A. A., Lee J. B. Radioimmunoassay of prostaglandin A. Intrarenal PGA2 as a factor mediating saline-induced natriuresis. Circ Res 1973; 33: 696
   PubMed Web of Science ®Google Scholar
• Bach G. L. Klinische Prüfung von Diclofenac Na (Voltaren) bei Arthrosen. Untersuchung möglicher Veränderungen der Dosen und ihrer Intervalle. Therapiewoche 1976; 26: 2958
   Google Scholar
• Brodie D. A., Cook P. G., Bauer B. J., Dagle G. E. Indomethacin-induced intestinal lesions in the rat. Toxicol Appl Pharmacol 1970; 17: 615
   PubMed Web of Science ®Google Scholar
• Ciccolunghi S. N., Chaudri H. A. Results of worldwide clinical trials with Voltaren. Chronic Forms of Polyarthritis, International Symposium, Torremolinos, F. J. Wagenhäuser. Huber, Berne, Stuttgart and Vienna 1975; 345, 1976
   Google Scholar
• Ciccolunghi S. N., Chaudri H. A., Schubiger B. I. Long-term trials in rheumatic indications–a series of compromises. Eular Bull Monograph Series No. 1, 1977; 135
   Google Scholar
• Duesing R., Melder B., Kramer H. J. Prostaglandins and renal function in acute extracellular volume expansion. Prostaglandins 1976; 12: 3
   PubMedGoogle Scholar
• Duggan D. E., Hooke K. F., Noll R. M., Kwan K. C. Enterohepatic circulation of indomethacin and its role in intestinal irritation. Biochem Pharmacol 1975; 25: 1749
   Web of Science ®Google Scholar
• Fehr K. Pathogenese der progredient chronischen Polyarthritis (PcP). Huber, Berne, Stuttgart and Vienna 1972
   Google Scholar
• Feigen L. P., Klainer E., Chapnick B. M., Kado-Vitz P. J. The effect of indomethacin on renal function in pentobarbital anaesthetized dog. J Pharmacol ExpTher 1976; 9S: 457
   Google Scholar
• Fine L. G., Trizna W. Influence of prostaglandins on sodium transport of isolated medullary nephron segments. Am J Physiol 1977; 232: F383
   Google Scholar
• Fried J. H., Harrison I. T., Lewis B., Riegl J., Rooks W., Tomolonis A. Structure activity relationship among 6-substituted-2-naphthylacetic acids. Scand J Rheumatol 1973; 7, Suppl. 2
   Google Scholar
• Frölich J. C., Hollifield J. W., Dormois J. C., Frolich B. L., Seyberth H., Michelakis A. M., Oates J. A. Suppression of plasma renin activity by indomethacin in man. Circ Res 1976; J9: 447
   Google Scholar
• Goulden A. Methods of Statistical Analysis. Wiley, New York 1960; 404
   Google Scholar
• Halim A. S., Sjöquist B., Ängård E. Inhibition of prostaglandin biosynthesis in rat brain. Acta Physiol Scand 1976; 109, Suppl. 440
   Google Scholar
• Hendershot L. C., Forsaith J. Antagonism of the frequency of phenylquinone-induced writhing in the mouse by weak analgesics and non-analgesics. J Pharmacol Exp Ther 1959; 125: 237
   PubMed Web of Science ®Google Scholar
• Jaques R. Antagonism of non-steroidal anti-inflammatory drugs and narcotic analgesics against etha-crynic acid induced writhing. Arzneim Forsch (Drug Res) 1977; 27: 1698
   PubMed Web of Science ®Google Scholar
• Krupp P. J., Exer B., Menassé-Gdynia R., Ziel R. Neue Aspekte der Entzündungshemmung durch nicht-steroide Antiphlogistika: Wirkung von Voltaren. Schweiz Med Wochenschr 1975; 105: 646
   PubMedGoogle Scholar
• Krupp P. J., Menassé-Gdynia R., Sallmann A., Wilhelmi G., Ziel R., Jaques R. Sodium [o-[(2,6-dichlorophenyl)-amino]-phenyl]-acetate (GP 45840), a new non-steroidal anti-inflammatory agent. Experientia 1973; 29: 450
   PubMedGoogle Scholar
• Krupp P., Menassé R., Ziel R. (1976) Chemistry and pharmacology of diclofenac. Voltaren, a New, Non-Steroid Antirheumatic Agent (Diclofenac), Proceedings of a Symposium held during the VHIth European Rheumatology Congress, Helsinki, 1975, F. J. Wagenhauser. Huber, Berne, Stuttgart and Vienna, 13
   Google Scholar
• Ku E. C., Wasvary J. M., Cash W. D. Diclofenac sodium (GP 45 840, Voltaren), a potent inhibitor of prostaglandin synthetase. Biochem Pharmacol 1975; 24: 641
   PubMed Web of Science ®Google Scholar
• Leo A., Hansch C., Elkins D. Partition coefficients and their uses. Chem Rev 1971; 77: 525
   Google Scholar
• Menassé-Gdynia R., Krupp P. J. Quantitative measurement of gastrointestinal bleeding in rats: the effect of nonsteroidal anti-inflammatory drugs. Toxicol Appl Pharmacol 1974; 29: 389
   PubMed Web of Science ®Google Scholar
• Moser P., Jäkel K., Krupp P., Menassé R., Sallmann A. Structure-activity relations of analogs of phenylbutazone. Eur J Med Chem 1975; 10: 613
   Web of Science ®Google Scholar
• Patak R. V., Mookerjee B. K., Bentzel C. J., Hy-Sert P. E., Babej M., Lee J. B. Antagonism of the effects of furosemide by indomethacin in normal and hypertensive man. Prostaglandins 1975; 649
   PubMed Web of Science ®Google Scholar
• Pearson C. M. Development of arthritis, periarthritis and periostitis in rats given adjuvants. Proc Soc Exp Biol Med 1956; 91: 95
   PubMed Web of Science ®Google Scholar
• Riess W., Stierlin H. Pharmacokinetics and metabolism of the anti-inflammatory agent Voltaren. Scand J Rheumatol 1978; 17, Suppl. 22
   PubMed Web of Science ®Google Scholar
• Riess W., Stierlin H., Geiger U.-P., Gérardin A., Schmid K., Wagner J., Theobald W. Data on the pharmacokinetics and metabolism of diclofenac (Voltaren) in animals and man. 302, loc. cit.5
   Google Scholar
• Riesterer L., Jaques R. The anti-inflammatory action of xanthine oxidase inhibitor (allopurinol). Pharmacology 1969; 2: 288
   PubMed Web of Science ®Google Scholar
• Roszkowski A. P., Rooks W. H., Tomolonis A. J., Miller L. M. Anti-inflammatory and analgesic properties of t/-2-(6′-methoxy-2′-naphthyl)-propionic acid (naproxen). J Pharmacol Exp Ther 1971; 179: 114
   PubMed Web of Science ®Google Scholar
• Sallmann A. 296, Chemical aspects of diclofenac: loc. cit.5
   Google Scholar
• Scherrer R. A., Winder C. V., Short F. W. The anti-inflammatory N-arylanthramlic acids. Abstracts of the IXth National Medicinal Chemistry Symposium of the American Chemical Society, Minneapolis, Minn, 1964, 11a–11a
   Google Scholar
• Shen T. Y. (1965) Synthesis and biological activity of some indomethacin analogs. International Symposium on Non-Steroidal Drugs, Milan, 1964, S. Garattini, M. N. G. Dukes. Excerpta Medica Foundation, Amsterdam, 13, International Congress Series No. 82
   Google Scholar
• Siraux P. Diclofenac (Voltaren) for the treatment of osteo-arthrosis: a double-blind comparison with naproxen. J Int Med Res 1977; 5: 169
   PubMed Web of Science ®Google Scholar
• Smith P. K., Hambourger W. E. The ratio of the toxicity of acetanilid to its antipyretic activity in rats. J Pharmacol Exp Ther 1936; 54: 346
   Google Scholar
• Somogyi A., Kovacs K., Selye H. Jejunal ulcers produced by indomethacin. J Pharm Pharmacol 1960; 21: 122
   Google Scholar
• Takeguchi C, Kokno E., Sih C. J. Mechanism of prostaglandin biosynthesis. I. Characterization and assay of bovine prostaglandin synthetase. Biochemistry 1971; 10: 2372
   Google Scholar
• Tiggeler R. G. W., Koene R. A. P., Wijdeveld P. G. A. B. Inhibition of frusemide-induced natri-uresis by indomethacin in patients with the nephrotic syndrome. Clin Sci Mol Med 1977; 52: 149
   PubMedGoogle Scholar
• Uthgenannt H., Timm H. Über den Einfluss von Voltaren auf die gastrointestinale Blutausscheidung. Münch Med Wochenschr 1975; 117: 1987
   Google Scholar
• Vane J. R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biol 1971; 231: 232
   PubMedGoogle Scholar
• Vane J. R. Prostaglandins in inflammation. Inflammation Mechanisms and Control, I. W. Le-Pow, P. A. Ward. Academic Press, New York and London 1972; 261
   Google Scholar
• White H. L., Glassman A. T. A simple radiochemical assay for prostaglandin synthetase. Prostaglandins 1974; 7: 123
   PubMedGoogle Scholar
• Winter C. A., Risley E. A., Nuss G. W. Car-rageenin-induced edema in hind paw of the rat as an assay for inflammatory drugs. Proc Soc Exp Biol Med 1963; 62: 544
   Google Scholar
• Wiseman E. H., Chiaini J. Anti-inflammatory and pharmacokinetic properties of sudoxicam N-(2-thia-zolyl)-4-hydroxy-2-methyl-2H-l,2-benzothiazine-3-carboxamide 1,1-dioxide. Biochem Pharmacol 1972; 21: 2323
   PubMed Web of Science ®Google Scholar
• Ziel R., Krupp P. Significance of the membrane-stabilizing effect of nonnarcotic analgesics. Advances in Pain Research and Therapy, J. J. Bonica, D. Albe-Fessard. Raven Press, New York 1976; Vol. I: 517
   Google Scholar